{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:36:07Z","timestamp":1791228967177,"version":"4.1.0"},"reference-count":32,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"unspecified","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["14707"],"award-info":[{"award-number":["14707"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,11,12]]},"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Cisplatin is a widely used chemotherapeutic anti-cancer drug. However, high-dose cisplatin is also known for its dose-limiting toxicities, including irreversible cisplatin-induced hearing loss (CIHL). Sodium thiosulphate (STS) can bind to cisplatin to form an inactive and harmless complex. A topical application is desired, allowing cisplatin to retain its systemic anti-cancer effect.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>\n                      The SOUND trial is an investigator-initiated randomised controlled multicentre phase III trial to study the efficacy of transtympanic administration of STS against CIHL in a cohort of 100 patients with head and neck cancer treated with cisplatin at a dose of \u2265200\u2009mg\/m\n                      <jats:sup>2<\/jats:sup>\n                      . Each subject will receive transtympanic STS injections in one ear, chosen by randomisation, before each cisplatin infusion. The contralateral ear serves as an internal control. The primary objective is efficacy (ie, clinically relevant benefit) of transtympanic STS injections against CIHL, defined as a difference in threshold shift of \u226510 decibels between baseline and 3\u2009months after treatment in favour of the STS-treated ear. Secondary objectives include the difference in mean threshold shifts on frequencies essential for speech and extended high frequencies, as well as the difference between both ears in the gradation of hearing loss as defined by ototoxicity grading scales.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The medical ethics committee in the Netherlands approved the trial (Clinical Trials Information System (CTIS) 2023-503313-30-00). The results will be disseminated through the CTIS and peer-reviewed scientific journals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>CTIS 2023-503313-30-00 approved by Medical Research Ethics Committee NedMec.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-107101","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T18:21:01Z","timestamp":1764786061000},"page":"e107101","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Transtympanic sodium thiosulphate to prevent cisplatin-related hearing loss: a protocol for randomised controlled multicentre phase III trial, the SOUND trial"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0435-3981","authenticated-orcid":false,"given":"Anouk V M","family":"Burger","sequence":"first","affiliation":[{"name":"Department of Head and Neck Surgery and Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands"},{"name":"Department of Otorhinolaryngology - Head and Neck surgery, Leiden University Medical Center, Leiden, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte W","family":"Duinkerken","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology - Head and Neck surgery, Leiden University Medical Center, Leiden, Netherlands"},{"name":"Department of Otolaryngology, Medical Centre Haaglanden, The Hague, ZH, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen C","family":"Jansen","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology - Head and Neck surgery, Leiden University Medical Center, Leiden, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stijn","family":"Keereweer","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology and Head and Neck Surgery, Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Froukje L","family":"Cals","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Radboud University Medical Center, Nijmegen, GE, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J","family":"Stokroos","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology-Head and Neck Surgery, University Medical Centre Utrecht, Utrecht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Paul","family":"de Boer","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie","family":"Exterkate","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilly-Ann","family":"van der Velden","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgery and Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander E","family":"Hoetink","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology-Head and Neck Surgery, University Medical Centre Utrecht, Utrecht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastiaan","family":"Nuijen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hauptmann","sequence":"additional","affiliation":[{"name":"Biometrie und Registerforschung, Brandenburg Medical School Theodor Fontane, Neuruppin, Brandenburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaske E","family":"van Sluis","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgery and Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5955-8453","authenticated-orcid":false,"given":"Tjasse D","family":"Bruintjes","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology - Head and Neck surgery, Leiden University Medical Center, Leiden, Netherlands"},{"name":"Gelre Hospitals, Apeldoorn, GE, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte L","family":"Zuur","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgery and Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands"},{"name":"Department of Otorhinolaryngology - Head and Neck surgery, Leiden University Medical Center, Leiden, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"2026010703460416000_15.12.e107101.1","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3390\/toxics3030268","article-title":"Cisplatin-Induced Ototoxicity: Effects, Mechanisms and Protection Strategies","volume":"3","author":"Callejo","year":"2015","journal-title":"Toxics"},{"key":"2026010703460416000_15.12.e107101.2","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1809394","article-title":"Cisplatin-Associated Ototoxicity: A Review for the Health Professional","volume":"2016","author":"Paken","year":"2016","journal-title":"J Toxicol"},{"key":"2026010703460416000_15.12.e107101.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2015.06.012"},{"key":"2026010703460416000_15.12.e107101.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5829.2007.00142.x"},{"key":"2026010703460416000_15.12.e107101.5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/jamaoto.2018.2876","article-title":"Incident Hearing Loss and Comorbidity: A Longitudinal Administrative Claims Study","volume":"145","author":"Deal","year":"2019","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"2026010703460416000_15.12.e107101.6","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1080\/14992027.2017.1353710","article-title":"Chemoradiation-induced hearing loss remains a major concern for head and neck cancer patients","volume":"57","author":"Schmitt","year":"2018","journal-title":"Int J Audiol"},{"key":"2026010703460416000_15.12.e107101.7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/hed.23551","article-title":"Sensorineural hearing loss in patients with head and neck cancer after chemoradiotherapy and radiotherapy: a systematic review of the literature","volume":"37","author":"Theunissen","year":"2015","journal-title":"Head Neck"},{"key":"2026010703460416000_15.12.e107101.8","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-2244"},{"key":"2026010703460416000_15.12.e107101.9","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2022.102203","article-title":"Global burden of ototoxic hearing loss associated with platinum-based cancer treatment: A systematic review and meta-analysis","volume":"79","author":"Dillard","year":"2022","journal-title":"Cancer Epidemiol"},{"key":"2026010703460416000_15.12.e107101.10","unstructured":"Federatie Medische S . Richtlijn hoofd-halstumoren, chemoradiatie en bioradiatie van hoofd-hals. 2014."},{"key":"2026010703460416000_15.12.e107101.11","doi-asserted-by":"crossref","first-page":"v184","DOI":"10.1093\/annonc\/mdq185","article-title":"Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"21 Suppl 5","author":"Gr\u00e9goire","year":"2010","journal-title":"Ann Oncol"},{"key":"2026010703460416000_15.12.e107101.12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.66.8822"},{"key":"2026010703460416000_15.12.e107101.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.heares.2006.09.015"},{"key":"2026010703460416000_15.12.e107101.14","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.603"},{"key":"2026010703460416000_15.12.e107101.15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.08.9540"},{"key":"2026010703460416000_15.12.e107101.16","doi-asserted-by":"publisher","DOI":"10.1159\/000095818"},{"key":"2026010703460416000_15.12.e107101.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0305-7372(03)00066-5"},{"key":"2026010703460416000_15.12.e107101.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2006.04.011"},{"key":"2026010703460416000_15.12.e107101.19","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0b013e31822e006d"},{"key":"2026010703460416000_15.12.e107101.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.joto.2017.12.001"},{"key":"2026010703460416000_15.12.e107101.21","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30625-8"},{"key":"2026010703460416000_15.12.e107101.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801109"},{"key":"2026010703460416000_15.12.e107101.23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5935\/0946-5448.20180007","article-title":"Transtympanic Injections of N-acetylcysteine and Dexamethasone for Prevention of Cisplatin-Induced Ototoxicity: Double Blind Randomized Clinical Trial","volume":"22","author":"Sarafraz","year":"2018","journal-title":"Int Tinnitus J"},{"key":"2026010703460416000_15.12.e107101.24","doi-asserted-by":"crossref","DOI":"10.1186\/s40463-019-0327-x","article-title":"A randomized controlled trial to test the efficacy of trans-tympanic injections of a sodium thiosulfate gel to prevent cisplatin-induced ototoxicity in patients with head and neck cancer","volume":"48","author":"Rolland","year":"2019","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"2026010703460416000_15.12.e107101.25","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/MAO.0000000000003069","article-title":"Transtympanic Sodium Thiosulfate for Prevention of Cisplatin-Induced Ototoxicity: A Randomized Clinical Trial","volume":"42","author":"Duinkerken","year":"2021","journal-title":"Otol Neurotol"},{"key":"2026010703460416000_15.12.e107101.26","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1200\/JCO.24.00905","article-title":"Randomized Phase Ib Clinical Trial of DB-020 Intratympanic Injections to Reduce High-Dose Cisplatin Ototoxicity","volume":"43","author":"Panizza","year":"2025","journal-title":"J Clin Oncol"},{"key":"2026010703460416000_15.12.e107101.27","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s10637-020-00918-1","article-title":"Phase 1 study to evaluate safety, tolerability and pharmacokinetics of a novel intra-tympanic administered thiosulfate to prevent cisplatin-induced hearing loss in cancer patients","volume":"38","author":"Viglietta","year":"2020","journal-title":"Invest New Drugs"},{"key":"2026010703460416000_15.12.e107101.28","doi-asserted-by":"publisher","DOI":"10.3109\/14992027.2013.781278"},{"key":"2026010703460416000_15.12.e107101.29","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3109\/14992027.2011.653448","article-title":"Validation of the THI-12 questionnaire for international use in assessing tinnitus: a multi-centre, prospective, observational study","volume":"51","author":"Bankstahl","year":"2012","journal-title":"Int J Audiol"},{"key":"2026010703460416000_15.12.e107101.30","first-page":"11","article-title":"Audiologic management of individuals receiving cochleotoxic drug therapy","volume":"36","year":"1994","journal-title":"ASHA"},{"key":"2026010703460416000_15.12.e107101.31","doi-asserted-by":"publisher","DOI":"10.1177\/0003489414534010"},{"key":"2026010703460416000_15.12.e107101.32","unstructured":"U.S. department of health and human services: common terminology criteria for adverse events (ctcae) version 5.0. 2017. Available: https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcae_v5_quick_reference_8.5x11.pdf"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-107101","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T11:47:10Z","timestamp":1767786430000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-107101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":32,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12,3]]},"published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1136\/bmjopen-2025-107101"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-107101","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]}}}